American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
Lead: Receipt of addiction treatment after nonfatal opioid overdose and risk of subsequent overdose: A retrospective cohort study
Tuesday 17th June 2025
Explore key findings from a study on addiction treatment post-opioid overdose and discover emerging therapies in addiction medicine.
8 minutes
Informative
Educational
Supportive
Engaging
Eye-opening
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
168 (View all)
Do you want to link to this podcast?
Get the buttons here!Unpacking Addiction Treatment: Insights from Opioid Overdose Study
Episode Overview
- A significant portion of patients receive no treatment after nonfatal opioid overdoses.
- Methadone and buprenorphine are effective in reducing subsequent overdoses.
- Cannabidiol shows promise in treating opioid use disorder.
- Psilocybin impacts spiritual attitudes and emotional processing.
- Surveillance is crucial for detecting unknown substances in drug supply.
56% of patients received no treatment after a nonfatal opioid overdose, highlighting a crucial intervention opportunity.
This episode of 'This Week in Addiction Medicine' from ASAM dives into the complexities of addiction treatment after a nonfatal opioid overdose. With a focus on a retrospective cohort study from Connecticut, the episode unpacks the critical moment for intervention that follows an overdose. The study reveals some startling statistics: 56% of patients received no treatment, while others received medication for opioid use disorder (MOUD) or inpatient care.
The findings highlight the effectiveness of methadone and buprenorphine in reducing subsequent overdoses, unlike detox or prolonged inpatient treatment. This underscores the urgent need to improve access to MOUD for those at high risk. The episode also takes a look at the potential role of cannabidiol (CBD) in treating opioid use disorder, with promising results from preclinical animal studies.
But it's not all about opioids; the episode explores the effects of psilocybin on spiritual attitudes among clergy and its impact on emotional processing in depression therapy. There’s also a fascinating discussion on Bromozolam exposure in overdose cases, highlighting the importance of substance surveillance. Listeners will find insights into novel treatments for cocaine use disorder and the role of GLP-1 receptor agonists in addressing alcohol-associated liver disease.
Each segment offers a glimpse into innovative research and therapies that could reshape addiction treatment. Whether you're interested in the nuances of opioid treatment or curious about psychedelic medicine, this episode offers a wealth of information. Tune in to understand how these findings could impact addiction medicine practices and patient care.